Neoadjuvant Imatinib Therapy for Dermatofibrosarcoma Protuberans

200969 citationsJournal Article

Authors

Anne Han · Icahn School of Medicine at Mount Sinai

Elbert H. Chen · Kaiser Permanente Rancho Cordova Medical Offices

George Niedt · Kaiser Permanente Rancho Cordova Medical Offices

William H. Sherman · Columbia University Irving Medical Center

Désirée Ratner · Columbia University Irving Medical Center

Abstract

Neoadjuvant imatinib therapy is a well-tolerated, novel approach to DFSP that reduces tumor burden and facilitates resection. Larger prospective studies are needed to confirm and expand on these results.

Topics & Keywords

Sarcoma Diagnosis and Treatment Tumors and Oncological Cases Soft tissue tumor case studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Dermatology

Volume 145, Issue 7, pp. 792-6

DOI: 10.1001/archdermatol.2009.140

Field-Weighted Citation Impact: 5.03